New York, NY, United States of America

Garo Armen

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Garo Armen. Retrieved from https://idiyas.com/inventor/garo-armen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Garo Armen: Innovator in PTSD Treatment

Introduction

Garo Armen is a notable inventor based in New York, NY (US). He has made significant contributions to the field of mental health, particularly in the treatment of post-traumatic stress disorder (PTSD). His innovative work has the potential to impact many lives.

Latest Patents

Garo Armen holds a patent for "Compositions, methods and uses for treating post-traumatic stress disorder." This patent describes compositions comprising a Teneurin C-terminal Associated Peptide-1 (TCAP-1) peptide. The methods and uses outlined in the patent focus on preventing and/or treating PTSD.

Career Highlights

Throughout his career, Garo Armen has worked with various companies, including Protagenic Therapeutics, Inc. His work in these organizations has contributed to advancements in therapeutic approaches for mental health conditions.

Collaborations

Garo has collaborated with notable individuals in his field, including David Lovejoy and Robert J. Stein. These partnerships have fostered innovation and development in the treatment of PTSD.

Conclusion

Garo Armen's contributions to the field of PTSD treatment through his patent and collaborations highlight his role as an influential inventor. His work continues to pave the way for new therapeutic methods that can benefit those affected by PTSD.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…